Stock Scorecard



Stock Summary for Becton Dickinson & Company (BDX) - $185.39 as of 2/23/2026 10:09:34 AM EST

Total Score

10 out of 30

Safety Score

45 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BDX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BDX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BDX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BDX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BDX (45 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for BDX

BD to Present at Barclays 28th Annual Global Healthcare Conference 2/24/2026 1:13:00 AM
How Full FDA Approval of ENHANCE Heart IDE at TransMedics Group (TMDX) Has Changed Its Investment Story 2/23/2026 10:31:00 PM
Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside 2/23/2026 8:42:00 PM
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency 2/23/2026 11:50:00 AM
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency 2/23/2026 11:50:00 AM
New BD urine test kit aims to cut repeat samples, reduce contamination 2/23/2026 11:49:00 AM
Becton Dickinson names Minnix general counsel 2/23/2026 11:44:00 AM
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading 2/23/2026 10:48:00 AM
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading 2/23/2026 10:48:00 AM
Evaluating Becton Dickinson (BDX) After Earnings Strength Guidance Reaffirmation And Debt Tender Activity 2/23/2026 7:50:00 AM

Financial Details for BDX

Company Overview

Ticker BDX
Company Name Becton Dickinson & Company
Country N/A
Description Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 12/31/2025
Next Earnings Date 4/29/2026

Stock Price History

Last Day Price 185.39
Price 4 Years Ago 241.14
Last Day Price Updated 2/23/2026 10:09:34 AM EST
Last Day Volume 2,740,168
Average Daily Volume 2,555,042
52-Week High 182.88
52-Week Low 126.26
Last Price to 52 Week Low 46.83%

Valuation Measures

Trailing PE N/A
Industry PE 829.73
Sector PE 148.47
5-Year Average PE 21.22
Free Cash Flow Ratio 51.50
Industry Free Cash Flow Ratio 24.75
Sector Free Cash Flow Ratio 31.12
Current Ratio Most Recent Quarter 1.05
Total Cash Per Share 3.60
Book Value Per Share Most Recent Quarter 88.79
Price to Book Ratio 1.98
Industry Price to Book Ratio 3.38
Sector Price to Book Ratio 33.63
Price to Sales Ratio Twelve Trailing Months 2.93
Industry Price to Sales Ratio Twelve Trailing Months 68.27
Sector Price to Sales Ratio Twelve Trailing Months 23.44
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 284,467,000
Market Capitalization 52,737,337,130
Institutional Ownership N/A

Dividends

Ex-Dividend Date 3/10/2026
Previous Dividend Amount 1.0500
Current Dividend Amount 1.0500
Total Years Dividend Increasing Dividend Aristocrat - Increasing for 41 Years
Trailing Annual Dividend Rate 4.17
Trailing Annual Dividend Yield 2.29%
Forward Annual Dividend Rate 4.20
Forward Annual Dividend Yield 2.30%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 2.73%
5-Year Average Dividend Yield 2.20%
1-Year Dividend Growth Rate Percentage 0.72%
3-Year Dividend Growth Rate Percentage 0.36%
5-Year Dividend Growth Rate Percentage 4.51%
All-Time Dividend Growth Rate Percentage 10.49%
Dividend Payout Ratio 68.14%

Income Statement

Quarterly Earnings Growth YOY 28.60%
Annual Earnings Growth -1.58%
Reported EPS 12 Trailing Months 6.12
Reported EPS Past Year 2.91
Reported EPS Prior Year 14.42
Net Income Twelve Trailing Months 1,757,000,000
Net Income Past Year 1,678,000,000
Net Income Prior Year 1,705,000,000
Quarterly Revenue Growth YOY 1.60%
5-Year Revenue Growth 6.32%
Operating Margin Twelve Trailing Months 13.40%

Balance Sheet

Total Cash Most Recent Quarter 1,024,000,000
Total Cash Past Year 851,000,000
Total Cash Prior Year 1,856,000,000
Net Cash Position Most Recent Quarter -15,892,000,000
Net Cash Position Past Year -16,770,000,000
Long Term Debt Past Year 17,621,000,000
Long Term Debt Prior Year 17,940,000,000
Total Debt Most Recent Quarter 16,916,000,000
Equity to Debt Ratio Past Year 0.59
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 25,390,000,000
Total Stockholder Equity Prior Year 25,889,000,000
Total Stockholder Equity Most Recent Quarter 25,282,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 2,631,000,000
Free Cash Flow Per Share Twelve Trailing Months 9.25
Free Cash Flow Past Year 2,670,000,000
Free Cash Flow Prior Year 3,073,000,000

Options

Put/Call Ratio 0.94
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.28
RSI 0.00
50-Day SMA 0.00
150-Day SMA 173.08
200-Day SMA 175.32

System

Modified 2/23/2026 6:25:35 PM EST